Stem Cells Translational Medicine · 2019 · 23 citations · 38 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryOrthopedic BiomaterialsRegenerative MedicineTissue EngineeringAllograft ReconstructionDecellularized Tissue ScaffoldsLigament ReconstructionMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyTendon ReconstructionBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsRabbit ModelsStem Cell-based ReconstructionTendon Tissue Engineering
As a regular adoptable material for anterior cruciate ligament (ACL) reconstruction, free tendon allograft exhibits unsatisfactory outcomes, such as retarded ligamentization and tendon-bone integration. The application of bone marrow-derived mesenchymal stem cells (BMSCs), as well as a decellularized free tendon allograft developed by our group, was proven to be effective in improving ACL reconstruction results. This study aimed to investigate the efficacy and feasibility of decellularized allogenic semitendinous tendon (ST) combined with autologous BMSCs used as a substitute to free tendon allograft in a rabbit model. This study finally shows that the decellularized allogenic ST combined with autologous BMSCs could significantly improve ACL reconstruction results compared with allograft. Stem Cells Translational Medicine 2019;8:971&982.
38
Host response to tissue engineered devices
Julia E. Babensee, James M. Anderson, Larry V. McIntire et al. · Advanced Drug Delivery Reviews · 1998 · 581 citations